Skip to main content
Fig. 3 | Cell Communication and Signaling

Fig. 3

From: Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells

Fig. 3

USP7 inhibitor upregulated c-Myc in cancer cells via USP22-dependent way. Western blot analysis of elevated c-Myc in A. A549 and B. HCT116 cancer cells treated with defined amounts of FT671 for 72h. C. FT671 treatment increased c-Myc-responsive luciferase reporter activity in H1299 cells in a dose-dependent manner, *p<0.05, ** p<0.01, compared to 0 (Vehicle). D. Western blot analysis of FT671-induced c-Myc in the parental (Wt) and USP22-Ko (Ko) H1299 cancer cells

Back to article page